Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells

被引：0
|
作者：
Eleanor O’Brien
Carmen Tse
Ian Tracy
Ian Reddin
Joanna Selfe
Jane Gibson
William Tapper
Reuben J. Pengelly
Jinhui Gao
Ewa Aladowicz
Gemma Petts
Khin Thway
Sergey Popov
Anna Kelsey
Timothy J. Underwood
Janet Shipley
Zoë S. Walters
机构：
[1] The Institute of Cancer Research,Divisions of Molecular Pathology and Cancer Therapeutics
[2] University of Southampton,Cancer Sciences, Faculty of Medicine
[3] University of Southampton,Human Development and Health, Faculty of Medicine
[4] Royal Marsden NHS Foundation Trust,Pathology Department
[5] Cardiff and Vale UHB,Cellular Pathology Department
[6] University of Manchester Foundation Trust,Department of Paediatric Pathology
来源：
Clinical Epigenetics | / 15卷
关键词：
Rhabdomyosarcoma; Differentiation therapy; Epigenetic therapy; EZH2; All-trans retinoic acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Growth differentiation factor 6, a repressive target of EZH2,promotes the commitment of human embryonic stem cells to mesenchymal stem cells
    Pend Deng
    Yongxin Yu
    Christine Hong
    Cun-Yu Wang
    Bone Research, 2020, (04) : 439 - 446
  • [42] Growth differentiation factor 6, a repressive target of EZH2, promotes the commitment of human embryonic stem cells to mesenchymal stem cells
    Pend Deng
    Yongxin Yu
    Christine Hong
    Cun-Yu Wang
    Bone Research, 8
  • [43] Growth differentiation factor 6, a repressive target of EZH2, promotes the commitment of human embryonic stem cells to mesenchymal stem cells
    Deng, Pend
    Yu, Yongxin
    Hong, Christine
    Wang, Cun-Yu
    BONE RESEARCH, 2020, 8 (01)
  • [44] Synergy in reversing platinum resistance by combined inhibition of EZH2 and EHMT1/2
    Brown, R.
    Kandil, S.
    Sundriyal, S.
    Fuchter, M.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S74 - S74
  • [45] Inhibition of EZH2 expression is associated with the proliferation, apoptosis, and migration of SW620 colorectal cancer cells in vitro
    He, Song-Bing
    Zhou, Hao
    Zhou, Jian
    Zhou, Guo-Qiang
    Han, Tuo
    Wan, Dai-Wei
    Gu, Wen
    Gao, Lin
    Zhang, Yi
    Xue, Xiao-Feng
    Zhang, Li-Feng
    Fei, Min
    Hu, Shui-Qing
    Yang, Xiao-Dong
    Zhu, Xin-Guo
    Wang, Liang
    Li, De-Chun
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 240 (04) : 458 - 466
  • [46] Genetic and pharmacological inhibition of retinoic acid receptor function promotes endochondral bone formation
    Uchibe, Kenta
    Son, Jiyeon
    Larmour, Colleen
    Pacifici, Maurizio
    Enomoto-Iwamoto, Motomi
    Iwamoto, Masahiro
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2017, 35 (05) : 1096 - 1105
  • [47] Enhancer of zeste homolog 2 (EZH2) inhibition in metastatic melanoma promotes tumor regression in vivo
    Sengupta, Deepanwita
    Avaritt, Nathan
    Shalin, Sara C.
    Tackett, Alan J.
    CANCER RESEARCH, 2016, 76
  • [48] Dual inhibition of EZH2 and histone deacetylases for the treatment of lymphomas with epigenetic aberrations
    Mensah, Afua Adjeiwaa
    Valente, Sergio
    Matkovic, Milos
    Sartori, Giulio
    Falzarano, Chiara
    Tarantelli, Chiara
    Cascione, Luciano
    Pileri, Stefano A.
    Cavalli, Andrea
    Mai, Antonello
    Bertoni, Francesco
    CANCER RESEARCH, 2022, 82 (12)
  • [49] Pharmacological inhibition of EZH2 by ZLD1039 suppresses tumor growth and pulmonary metastasis in melanoma cells in vitro and in vivo
    Zhu, Yongxia
    Zhang, Lidan
    Song, Xuejiao
    Zhang, Qiangsheng
    Wang, Ting
    Xiao, Hongtao
    Yu, Luoting
    BIOCHEMICAL PHARMACOLOGY, 2023, 210
  • [50] Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription
    Wang, Miao
    Guo, Chen
    Wang, Liang
    Luo, Gang
    Huang, Chao
    Li, Yawei
    Liu, Dong
    Zeng, Fuqing
    Jiang, Guosong
    Xiao, Xingyuan
    CELL DEATH & DISEASE, 2018, 9
12345